SEKHRI PAUL J

SEC Form 4 insider trading activity

SEKHRI PAUL J has filed 6 SEC Form 4 filings (7 transaction rows) across 2 companies, including VEEV, APMD, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Sep 3, 2026.

On the most recent filing, SEKHRI PAUL J is listed as Director at Apnimed, Inc. Inside the rolling window, SEKHRI PAUL J reported 1 open-market purchase totaling $200K in APMD and no open-market sales.

Companies traded

Other insiders at VEEV

Insider Buying

$200K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

2

in the rolling window

Source
APMD
SEKHRI PAUL J
Purchase$200KAug 3SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has SEKHRI PAUL J made?

SEKHRI PAUL J has filed 6 SEC Form 4 filings (7 transaction rows) across 2 companies, including VEEV, APMD since 2025.

Which companies does SEKHRI PAUL J trade?

SEKHRI PAUL J has filed SEC Form 4 disclosures for 2 companies, including VEEV, APMD.

When was SEKHRI PAUL J's most recent SEC Form 4 filing?

SEKHRI PAUL J's most recent SEC Form 4 filing on Tracefour is dated Sep 3, 2026.

What is SEKHRI PAUL J's total buy and sell value in the current window?

Inside the rolling retention window, SEKHRI PAUL J bought $200K and sold $0 based on SEC Form 4 filings.

What was SEKHRI PAUL J's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 12,500 APMD shares on 2026-08-03, worth $200K, per SEC Form 4 filings.